Results 181 to 190 of about 299,453 (315)
A Wasserstein-Space-Based Framework for Processing Fiber Orientation Geometry in Diffusion MRI. [PDF]
Nie X, Shi Y.
europepmc +1 more source
Advanced Diffusion MRI : Non-Gaussian Analysis for the Clinic
Yuichi Suzuki, Osamu Abe
openalex +2 more sources
This study demonstrates that HDAC1/2 knockout in microglia alleviates neurological deficits, preserves white matter, and accelerates hematoma clearance after ICH. HDAC1/2 inhibition reduces HK2 acetylation, shifts metabolism from glycolysis to fatty acid oxidation, reduces inflammation, and enhances phagocytosis.
Zhiwen Jiang +9 more
wiley +1 more source
<i>TORTOISEV4</i>: Reimagining the NIH diffusion MRI processing pipeline. [PDF]
Irfanoglu MO +4 more
europepmc +1 more source
Genome‐Wide by Lifetime Environment Interaction Studies of Brain Imaging Phenotypes
This study explores genome‐wide by lifetime environment interactions on brain imaging phenotypes. Gene‐environment interactions explain more phenotypic variance than main effects, pinpoint regulatory variants, and reveal exposure‐specific biological pathways.
Sijia Wang +51 more
wiley +1 more source
Effect of a consistent reconstruction algorithm on inter-scanner reproducibility in diffusion MRI. [PDF]
Liu Q +8 more
europepmc +1 more source
Circular RNA PTPN4 Contributes to Blood‐Brain Barrier Disruption during Early Epileptogenesis
Epileptic condition induces CircPTPN4 upregulation, which promotes ECE‐1 expression through competitive sequestration of miR‐145a‐5p. The elevated ECE‐1 catalyzes the ET‐1 production, leading to p38/MAPK pathway activation and subsequent downregulation of tight junction protein expression. This cascade results in increased BBB permeability and enhanced
Jiurong Yang +16 more
wiley +1 more source
Susceptibility and diffusion MRI biomarkers predict development of Parkinsonism in iRBD. [PDF]
Varga Z +8 more
europepmc +1 more source
Heterogeneous cancer‐associated fibroblasts orchestrate dual immune microenvironments in LAGC. Abstract The potential for immunotherapy in patients with locally advanced gastric cancer (LAGC) is recently confirmed. To report the 3‐year follow‐up data are aimed from a novel clinical trial. This is a prospective single‐arm phase II trial.
Yao Lin +14 more
wiley +1 more source

